PPARGC1A and melanoma: Relieving hypoxia in TME by reducing oxygen consumption of engineered tumor cells or regulating hypoxia response factor by overexpression of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α) in T cells results in a significantly reduced subset of T-cell exhaustion in the melanoma mouse model (31).